Skip to main content
SpringerLink
Log in

The mTOR/p70S6K Signal Transduction Pathway Plays a Role in Cardiac Hypertrophy and Influences Expression of Myosin Heavy Chain Genes in vivo

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Objective: Rapamycin (R) inhibits p70 S6 kinase (p70S6K) activity and hypertrophy of cultured neonatal rat cardiac myocytes. The purpose of the present study was to determine whether rapamycin inhibits left ventricular (L V) hypertrophy in intact rats and whether it alters cardiac gene expression.

Methods: 300 g rats were subjected to aortic constriction (AC) or sham-operation (SH) and studied 2 and 3 days after surgery. Beginning 1 day prior to surgery, rats were injected with rapamycin (1.5 mg/kg, i.p.) or carboxymethylcellulose vehicle (V), yielding 4 groups (SH-V, SH-R, AC-V, AC-R). Total RNA was extracted for determination of mRNA levels by Northern blotting.

Results: L V dry weight/body weight ratios were 0.43 ± 0.04 (mean ± SE) for SH-V, 0.46 ± 0.02 for SH-R, 0.56 ± 0.02 for AC-V, and 0.53 ± 0.03 for AC-R. R inhibited cardiac hypertrophy induced by pressure overload (ANOVA; p < 0.05). Rapamycin had no effect on the expression of atrial natriuretic factor mRNA, but increased the levels of β-myosin heavy chain mRNA 6-fold in hearts of SH-R and AC-R compared to SH-V. Rapamycin also increased the expression of α-myosin heavy chain mRNA in SH-R by 3-fold compared with SH-V, but had no effect on the AC-R group.

Conclusion: The data suggest that an intact mTOR signaling pathway is required for rapid hypertrophic growth of the heart in vivo. Moreover, the data suggest a novel link between the mTOR/p70S6K signal transduction pathway and pretranslational control of myosin gene expression in the heart.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sugden PH, Clerk A. Cellular mechanisms of cardiac hyper-trophy. J MolMed 1998;76:725–746.

    Google Scholar 

  2. Cooper G 4th. Basic determinants of myocardial hypertro-phy: A review of molecular mechanisms. Annu Rev Med 1997;48:13–23.

    Google Scholar 

  3. Morgan HE, Gordon EE, Kira Y, et al. Biochemical mechanisms of cardiac hypertrophy. Annu Rev Physiol 1987;49:533–543.

    Google Scholar 

  4. Zak R, Rabinowitz M. Molecular aspects of cardiac hyper-trophy. Annu Rev Physiol 1979;41:539–552.

    Google Scholar 

  5. Kozma S, Thomas G. Regulation of cell size in growth, devel-opment and human disease: PI3K, PKB and S6K. Bioessays 2002;24:65–71.

    Google Scholar 

  6. Montagne J, Stewart MJ, Stocker H, Hafen E, Kozma SC, Thomas G. Drosophila S6 kinase: A regulator of cell size. Science 1999;285:2126–2129.

    Google Scholar 

  7. Baar K, Esser K. Phosphorylation of p70S6k correlates with increased skeletal muscle mass following resistance exer-cise. Am J Physiol 1999;276:C120-C127.

    Google Scholar 

  8. Bodine SC, Stitt TN, Gonzalez M, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001;3:1014- 1019.

    Google Scholar 

  9. Sadoshima J, Izumo S. Rapamycin selectively inhibits an-giotensin induced increase in protein synthesis in car-diac myocytes in vitro: Potential role of 70-kD S6 ki-nase in angiotensin-induced cardiac hypertrophy. Circ Res 1995;77:1040–1052.

    Google Scholar 

  10. Boluyt MO, Zheng JS, Younes A, et al. Rapamycin in-hibits α 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes: Evidence for involvement of p70 S6 kinase. Circ Res 1997;81:176–186.

    Google Scholar 

  11. Laser M, Kasi VS, Hamawaki M, Cooper IV G, Kerr CM, Kuppuswamy D. Differential activation of p70 and p85 S6 ki-nase isoforms during cardiac hypertrophy in the adult mam-mal. J Biol Chem 1998;273:24610–24619.

    Google Scholar 

  12. Nygard O, Nilsson L. Translational dynamics: Interactions between the translational factors, tRNA,and ribosomes dur-ing eukaryotic protein synthesis. Eur J Biochem 1990;191:1- 17.

    Google Scholar 

  13. Jeffries HJB, Reinhard C, Kozma SC, Thomas G. Rapamycin selectively represses translation of the “polypyrimidine tract” mRNAfamily. Proc Natl Acad Sci USA1994;91:4441- 4445.

    Google Scholar 

  14. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and sig-naling by the 70 kd S6 protein kinases. Cell 1992;69:1227- 1236.

    Google Scholar 

  15. Brown EJ, Schreiber SL. A signaling pathway to transla-tional control. Cell 1996;86:517–520.

    Google Scholar 

  16. Nourse J, Firpo E, Flanagan WM, et al. Interleukin-2-mediated elimination of the p27 KIP1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994;372:570- 573.

    Google Scholar 

  17. Schreiber SL. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 1991;251:283- 287.

    Google Scholar 

  18. Chang JY, Sehgal SN, Bansbach CC. FK506 and rapamycin: Novel pharmacological probes of the immune response. Trends Pharmacol Sci 1991;12:218–223.

    Google Scholar 

  19. Kunz J, Hall MN. Cyclosporin A, FK506 and rapamycin: More than just immunosuppression. Trend Biochem Sci 1993;18:334–338.

    Google Scholar 

  20. Levy S, Avni D, Hariharan N, Perry RP, Meyuhas O. Oligopyrimidine tract at the 5' end of mammalian ribosomal protein mRNAs is required for their translational control. Proc Natl Acad Sci USA 1991;88:3319–3323.

    Google Scholar 

  21. Terada N, Patel HR, Takase K, Kohno K, Nairn AC, Gelfand EW. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci USA 1994;91:11477–11481.

    Google Scholar 

  22. Siehl D, Chua BHL, Lautensack-Belser N, Morgan HE. Faster protein and ribosome synthesis in thyroxine-induced hypertrophy of rat heart. Am J Physiol 1985;248:C309- C319.

    Google Scholar 

  23. Bishopric NH, Simpson PC, Ordahl CP. Induction of the skeletal á-actin gene in α1-adrenoceptor-mediated hypertro-phy of rat cardiac myocytes. J Clin Invest 1987;80:1194–1199.

    Google Scholar 

  24. Boluyt MO, Opiteck JA, Esser KE, White TP. Cardiac adap-tations to aortic constriction in adult and aged rats. Am J Physiol 1989;257:H643-H648.

    Google Scholar 

  25. Boluyt MO, O'Neill L, Meredith AL, et al. Alterations in cardiac gene expression during the transition from sta-ble hypertrophy to heart failure. Marked upregulation ofgenes encoding extracellular matrix components. Circ Res 1994;75:23–32.

    Google Scholar 

  26. Zheng JS, Boluyt MO, O'Neill L, Crow MT, Lakatta EG. Extracellular ATPinduces immediate-early gene expression but not cellular hypertrophy in neonatal cardiac myocytes. Circ Res 1994;74:1034–1041.

    Google Scholar 

  27. Blake MJ, Fargnoli J, Gershon D, Holbrook NJ. Concomitant decline in heat-induced hyperthermia and HSP70 mRNA expression in aged rats. Am J Physiol 1991;260:R663- R667.

    Google Scholar 

  28. Long X, Crow MT, Sollott SJ, et al. Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar pro-ton ATPase in cardiomyocytes. J Clin Invest 1998;101:1453- 1461.

    Google Scholar 

  29. Izumo S, Nadal-Ginard B, Mahdavi V. Protooncogene induc-tion and reprogramming of cardiac gene expression pro-duced by pressure overload. Proc Natl Acad Sci USA 1988;85:339–343.

    Google Scholar 

  30. Chien KR, Knowlton KU, Zhu H, Chien AS. Regulation of cardiac gene expression during myocardial growth and hy-pertrophy: Molecular studies of an adaptive physiologic re-sponse. FASEB J 1991;5:3037–3046.

    Google Scholar 

  31. Schneider MD, Packer SE, Parker TG. Peptide growth fac-tors can provoke “fetal” contractile protein gene expression in rat cardiac myocytes. J Clin Invest 1990;85:507–514.

    Google Scholar 

  32. Baliga RR, Pimental DR, Zhao YY, et al. NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK. Am J Physiol 1999;277:H2026- H2037.

    Google Scholar 

  33. Simm A, Schluter K, Diez C, Piper HM, Hoppe J. Acti-vation of p70(S6) kinase by beta-adrenoceptor agonists on adult cardiomyocytes. J Mol Cell Cardiol 1998;30:2059- 2067.

    Google Scholar 

  34. Park IH, Bachmann R, Shirazi H, Chen J. Regulation of ri-bosomal S6 kinase 2 by mammalian target of rapamycin. J Biol Chem 2002;277:31423–429.

    Google Scholar 

  35. Shioi T, McMullen JR, Tarnavski O, et al. Rapamycin attenu-ates load-induced cardiac hypertrophy in mice. Circulation 2003;107:1664–1670.

    Google Scholar 

  36. deGroot RP, Ballou LM, Sassone Corsi P. Positive regula-tion of the cAMP-responsive activator CREM by the p70 S6 kinase: An alternative route to mitogen-induced gene ex-pression. Cell 1994;79:81–91.

    Google Scholar 

  37. Hasegawa K, Lee SJ, Jobe SM, Markham BE, Kitsis RN. cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hyper-trophy due to aortic constriction. Circulation 1997;96:3943- 3953.

    Google Scholar 

  38. Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: A review of the evidence. Kidney Int 2001;59:3–16.

    Google Scholar 

  39. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: Anewtherapeutic target? Circulation 2004;109:1580- 1589.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Molecular Kinesiology, The University of Michigan, Ann Arbor, MI, 48109-2214, USA

    Marvin O. Boluyt, Zhao Bo Li, Amy M. Loyd, Antony F. Scalia, Georgina M. Cirrincione & Rebecca R. Jackson

Authors
  1. Marvin O. Boluyt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhao Bo Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amy M. Loyd
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antony F. Scalia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Georgina M. Cirrincione
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rebecca R. Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boluyt, M.O., Li, Z.B., Loyd, A.M. et al. The mTOR/p70S6K Signal Transduction Pathway Plays a Role in Cardiac Hypertrophy and Influences Expression of Myosin Heavy Chain Genes in vivo. Cardiovasc Drugs Ther 18, 257–267 (2004). https://doi.org/10.1023/B:CARD.0000041245.61136.56

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:CARD.0000041245.61136.56

Search

Navigation